Gepotidacin for the Treatment of Uncomplicated Urogenital Gonorrhea: A Phase 2, Randomized, Dose- Ranging, Single-Oral Dose Eva
New Antibiotic for Urinary-Tract Infections Found Effective in Trials - WSJ
Gepotidacin for Urinary Tract Infection Clinical Trial 2023 | Power
GSK stops two Phase 3 studies for gepotidacin stopped early
With endpoints already met, GSK halts trial into new antibiotic
Antibiotics | Free Full-Text | Antibacterial Activity of the Novel Drug Gepotidacin against Stenotrophomonas maltophilia—An In Vitro and In Vivo Study
Design of Two Phase III, Randomized, Multicenter Studies Comparing Gepotidacin with Nitrofurantoin for the Treatment of Uncomplicated Urinary Tract Infection in Female Participants | SpringerLink
gepotidacin - Drug Hunter
Dose Selection for Phase III Clinical Evaluation of Gepotidacin (GSK2140944) in the Treatment of Uncomplicated Urinary Tract Infections | Antimicrobial Agents and Chemotherapy
Dose Selection for Phase 3 Studies Evaluating Gepotidacin (GSK2140944) in the Treatment of Uncomplicated Urinary Tract Infections | GSK
TITLE PAGE
Safety Trial of New Antibiotic - YouTube
Dose selection for a phase III study evaluating gepotidacin (GSK2140944) in the treatment of uncomplicated urogenital gonorrhoea | Sexually Transmitted Infections
Novel drug gepotidacin for uncomplicated UTI meets trial goals
Dose Selection for Phase 3 Studies Evaluating Gepotidacin (GSK2140944) in the Treatment of Uncomplicated Urinary Tract Infections | GSK
GSK initiates Phase III programme of gepotidacin antibiotic
Pharmacokinetics of Oral Formulations of Gepotidacin (GSK2140944), a Triazaacenaphthylene Bacterial Type II Topoisomerase Inhibitor, in Healthy Adult and Adolescent Participants | Antimicrobial Agents and Chemotherapy
Design of Two Phase III, Randomized, Multicenter Studies Comparing Gepotidacin with Nitrofurantoin for the Treatment of Uncomplicated Urinary Tract Infection in Female Participants | SpringerLink
Dose Selection for Phase III Clinical Evaluation of Gepotidacin (GSK2140944) in the Treatment of Uncomplicated Urinary Tract Infections | Antimicrobial Agents and Chemotherapy
Antibiotics | Free Full-Text | Pharmaceutical Approaches on Antimicrobial Resistance: Prospects and Challenges
Pharmacokinetics, safety, and tolerability of gepotidacin administered as single or repeat ascending doses, in healthy adults and elderly subjects - Tiffany - 2022 - Clinical and Translational Science - Wiley Online Library
How to Treat Urinary Tract Infections (UTI): GSK's Gepotidacin May Work - Bloomberg
